Literature DB >> 17430618

The antinociceptive efficacy of buprenorphine administered through the drinking water of rats.

L Jessen1, S Christensen, O J Bjerrum.   

Abstract

Postoperative pain management in laboratory animals is important for animal welfare and required under law in many countries. Frequent injection of analgesics to rodents after surgery is stressful for the animals and labour-intensive for animal care personnel. An alternative dosing scheme such as administration of analgesics in the drinking water would be desirable. However, the efficacy of a chronic oral analgesic treatment via this route has not yet been documented. This study investigated the antinociceptive efficacy of buprenorphine administered ad libitum via the drinking water of laboratory rats. The antinociceptive efficacy of buprenorphine in drinking water was compared with repeated subcutaneous injections. A comparison was also made between buprenorphine in drinking water and the combination of one single subcutaneous injection of buprenorphine followed by buprenorphine in drinking water. Antinociception was assessed by use of an analgesiometric model measuring the rats' latency time to withdrawal from a noxious heat stimulus applied to the plantar surface of the paw. Results revealed that buprenorphine in drinking water (0.056 mg/mL) induced significant increases in paw withdrawal latency times during a three-day period of administration with a maximal effect at 39 h after the start of buprenorphine administration. One single injection of buprenorphine (0.1 mg/kg s.c.) followed by buprenorphine in the drinking water (0.056 mg/mL) induced an earlier onset of antinociception than buprenorphine in drinking water alone. In contrast, buprenorphine (0.1 mg/kg s.c.) injected every 8 h over a period of three days did not result in significant increases in paw withdrawal latency times. In conclusion, our results suggest that one single subcutaneous injection of buprenorphine followed by buprenorphine in drinking water may be a viable treatment option for the relief of pain in laboratory rats, but at the doses used in this study in pain-free rats it was associated with a decrease in water intake and some behavioural changes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430618     DOI: 10.1258/002367707780378131

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  14 in total

1.  Antinociceptive effects of sustained-release buprenorphine in a model of incisional pain in rats (Rattus norvegicus).

Authors:  Helen H Chum; Katechan Jampachairsri; Gabriel P McKeon; David C Yeomans; Cholawat Pacharinsak; Stephen A Felt
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-03       Impact factor: 1.232

2.  Effects of buprenorphine, meloxicam, and flunixin meglumine as postoperative analgesia in mice.

Authors:  Jacquelyn T Tubbs; Grace E Kissling; Greg S Travlos; David R Goulding; James A Clark; Angela P King-Herbert; Terry L Blankenship-Paris
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-03       Impact factor: 1.232

3.  Extended-release Buprenorphine, an FDAindexed Analgesic, Attenuates Mechanical Hypersensitivity in Rats (Rattus norvegicus).

Authors:  Eden D Alamaw; Benjamin D Franco; Katechan Jampachaisri; Monika K Huss; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2021-12-16       Impact factor: 1.706

4.  Correlation between body weight changes and postoperative pain in rats treated with meloxicam or buprenorphine.

Authors:  Matthew P Brennan; Albert J Sinusas; Tamas L Horvath; J G Collins; Martha J Harding
Journal:  Lab Anim (NY)       Date:  2009-03       Impact factor: 12.625

5.  Analgesic Activity of Tramadol and Buprenorphine after Voluntary Ingestion by Rats (Rattus norvegicus).

Authors:  Bryan F Taylor; Harvey E Ramirez; August H Battles; Karl A Andrutis; John K Neubert
Journal:  J Am Assoc Lab Anim Sci       Date:  2016-01       Impact factor: 1.232

6.  Analgesic Efficacy and Safety of Buprenorphine in Chinchillas (Chinchilla lanigera).

Authors:  Lana Fox; Christoph Mans
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-04-24       Impact factor: 1.232

7.  Clinical Management of Pain in Rodents.

Authors:  Patricia L Foley; Lon V Kendall; Patricia V Turner
Journal:  Comp Med       Date:  2019-12-10       Impact factor: 0.982

8.  Transdermal Fentanyl Solution Provides Long-term Analgesia in the Hind-paw Incisional Model of Postoperative Pain in Male Rats.

Authors:  Johanne Clemensen; Lena V Rasmussen; Klas S P Abelson
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

9.  Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.

Authors:  Katie J Schenning; Sarah Holden; Brett A Davis; Amelia Mulford; Kimberly A Nevonen; Joseph F Quinn; Jacob Raber; Lucia Carbone; Nabil J Alkayed
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post-operative hypersensitivity in an incisional pain model in mice (Mus musculus).

Authors:  Kaela Navarro; Katechan Jampachaisri; Monika Huss; Cholawat Pacharinsak
Journal:  Animal Model Exp Med       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.